{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T21:40:40Z","timestamp":1772574040675,"version":"3.50.1"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,1,13]],"date-time":"2021-01-13T00:00:00Z","timestamp":1610496000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,1,13]],"date-time":"2021-01-13T00:00:00Z","timestamp":1610496000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>West Nile virus (WNV) infections have become increasingly prevalent in certain European countries, including Hungary. Although most human infections do not cause severe symptoms, in approximately 1% of cases WNV infections can lead to severe WNV neuroinvasive disease (WNND) and death. The goal of our study was to assess the neurological status changes of WNV \u2013infected patients admitted to inpatient care and to identify potential risk factors as underlying reasons for severe neurological outcome.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We conducted a retrospective chart review of 66 WNV-infected patients from four Hungarian medical centers. Patients\u2019 neurological status at hospital admission and at two follow-up intervals (1st follow-up, within 60\u201390\u2009days and 2nd follow-up, within 150\u2013180\u2009days, after hospital discharge) were assessed. All of the 66 patients in the initial sample had some type of neurological symptoms and 56 patients were diagnosed with WNND. The modified Rankin Scale (mRS) and the West Nile Virus Neurological Index (WNV-N Index), a scoring system designed for the purpose of this study, were used for neurological status assessment. Patients were dichotomized into two categories, \u201cmoderately severe\u201d and \u201csevere\u201d based on their neurological status. Descriptive analysis for sample description, stratified analysis for calculation of odds ratio (OR) and logistic regression for continuous input variables, were performed.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The average number of days between the onset of neurological symptoms and hospital admission (the neurological symptom interval) was 6.01\u2009days. Complications during the hospital stay arose in almost a fifth of the patients (18.2%) and 5 patients died. Each day\u2019s increase in the neurological symptom interval significantly increased the risk for developing a severe neurological status following hospital admission (0.799-fold and 0.688-fold, based on the WNV-N Index and mRS, respectively). Patients\u2019 age, comorbidity, presence of complications and symptoms of malaise, and gait uncertainty were shown to be independent risk factors for severe neurological status.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Timely hospital admission of patients with neurological symptoms as well as risk assessment by clinicians - possibly with an optimal assessment tool for estimating neurological status- could improve the neurological outcome of WNV-infected patients.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12879-020-05760-7","type":"journal-article","created":{"date-parts":[[2021,1,13]],"date-time":"2021-01-13T08:04:13Z","timestamp":1610525053000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Identifying risks for severity of neurological symptoms in Hungarian West Nile virus patients"],"prefix":"10.1186","volume":"21","author":[{"given":"M\u00e1rton","family":"Koch","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c9va","family":"Pozsgai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Viktor","family":"So\u00f3s","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Nagy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00e1nos","family":"Gir\u00e1n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norbert","family":"Nyisztor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tibor","family":"Martyin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zs\u00f3fia","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mel\u00e1nia","family":"Feh\u00e9r","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edit","family":"Hajd\u00fa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Csaba","family":"Varga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,1,13]]},"reference":[{"issue":"1","key":"5760_CR1","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1002\/mus.25660","volume":"57","author":"P Athar","year":"2018","unstructured":"Athar P, Hasbun R, Nolan MS, Salazar L, Woods SP, Sheikh K, et al. Long-term neuromuscular outcomes of West Nile virus infection: A clinical and electromyographic evaluation of patients with a history of infection. Muscle Nerve. 2018;57(1):77\u201382 [cited 2020 Aug 26] Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/28380696\/.","journal-title":"Muscle Nerve"},{"key":"5760_CR2","doi-asserted-by":"publisher","unstructured":"Hart J, Tillman G, Kraut MA, et al. West Nile virus neuroinvasive disease: neurological manifestations and prospective longitudinal outcomes. BMC Infect Dis. 2014;14:248. https:\/\/doi.org\/10.1186\/1471-2334-14-248.","DOI":"10.1186\/1471-2334-14-248"},{"key":"5760_CR3","unstructured":"West Nile virus infection - Annual Epidemiological Report for 2018 [Internet]. [cited 2020 Aug 26]. Available from: https:\/\/www.ecdc.europa.eu\/en\/publications-data\/west-nile-virus-infection-annual-epidemiological-report-2018."},{"key":"5760_CR4","unstructured":"Epidemiological update: West Nile virus transmission season in Europe, 2018 [Internet]. [cited 2020 Aug 26]. Available from: https:\/\/www.ecdc.europa.eu\/en\/news-events\/epidemiological-update-west-nile-virus-transmission-season-europe-2018."},{"issue":"51","key":"5760_CR5","doi-asserted-by":"publisher","first-page":"2026","DOI":"10.1556\/650.2019.31575","volume":"160","author":"M Koch","year":"2019","unstructured":"Koch M, T\u00f6r\u00f6k KT, Nagy F, So\u00f3s V, Pozsgai \u00c9, Lelovics Z, et al. The occurrence of neuroinvasive symptoms caused by the West Nile virus at an emergency center. Orv Hetil. 2019;160(51):2026\u201335 [cited 2020 Aug 31] Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/31838862\/.","journal-title":"Orv Hetil"},{"key":"5760_CR6","doi-asserted-by":"crossref","unstructured":"Petersen LR, Brault AC, Nasci RS. West Nile virus: Review of the literature [Internet]. JAMA. 2013;310:308\u201315 [cited 2020 Aug 26] Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/23860989\/.","DOI":"10.1001\/jama.2013.8042"},{"issue":"1","key":"5760_CR7","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s12028-017-0500-x","volume":"29","author":"MA Hawkes","year":"2018","unstructured":"Hawkes MA, Carabenciov ID, EFM W, Rabinstein AA. Critical west nile neuroinvasive disease. Neurocrit Care. 2018;29(1):47\u201353 [cited 2020 Aug 26] Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/29435806\/.","journal-title":"Neurocrit Care"},{"issue":"8","key":"5760_CR8","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.3201\/eid1008.030879","volume":"10","author":"AL Klee","year":"2004","unstructured":"Klee AL, Maldin B, Edwin B, Poshni I, Mostashari F, Fine A, et al. Long-term prognosis for clinical West Nile virus infection. Emerg Infect Dis. 2004;10(8):1405\u201311 [cited 2020 Aug 26] Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/15496241\/.","journal-title":"Emerg Infect Dis"},{"issue":"5","key":"5760_CR9","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.4269\/ajtmh.14-0616","volume":"92","author":"JE Weatherhead","year":"2015","unstructured":"Weatherhead JE, Miller VE, Garcia MN, Hasbun R, Salazar L, Dimachkie MM, et al. Long-term neurological outcomes in West Nile virus-infected patients: An observational study. Am J Trop Med Hyg. 2015;92(5):1006\u201312 [cited 2020 Aug 26] Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/25802426\/.","journal-title":"Am J Trop Med Hyg"},{"issue":"12","key":"5760_CR10","doi-asserted-by":"publisher","first-page":"1918","DOI":"10.3201\/eid1312.061265","volume":"13","author":"CM Jean","year":"2007","unstructured":"Jean CM, Honarmand S, Louie JK, Glaser CA. Risk factors for West Nile virus neuroinvasive disease, California, 2005. Emerg Infect Dis. 2007;13(12):1918\u201320 [cited 2020 Aug 26] Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/18258047\/.","journal-title":"Emerg Infect Dis"},{"key":"5760_CR11","doi-asserted-by":"publisher","unstructured":"Popescu CP, Florescu SA, Hasbun R, et al. Prediction of unfavorable outcomes in West Nile virus neuroinvasive infection - Result of a multinational ID-IRI study. J Clin Virol. 2020;122:104213. https:\/\/doi.org\/10.1016\/j.jcv.2019.104213.","DOI":"10.1016\/j.jcv.2019.104213"},{"key":"5760_CR12","doi-asserted-by":"publisher","unstructured":"Nagy A, Mezei E, Nagy O, et al. Extraordinary increase in West Nile virus cases and first confirmed human Usutu virus infection in Hungary, 2018. Euro Surveill. 2019;24(28):1900038. https:\/\/doi.org\/10.2807\/1560-7917.ES.2019.24.28.1900038.","DOI":"10.2807\/1560-7917.ES.2019.24.28.1900038"},{"key":"5760_CR13","unstructured":"2012\/506\/EU: Commission Implementing Decision of 8 August 2012 amending Decision 2002\/253\/EC laying down case definitions for reporting communicable diseases to the Community network under Decision No 2119\/98\/EC of the European Parliament and of the Council (notified under document C(2012) 5538) Text with EEA relevance [Internet]. Op.europa.eu. 2012 [cited 5 January 2021]. Available from: https:\/\/op.europa.eu\/en\/publication-detail\/-\/publication\/10ed460f-0711-11e2-8e28-01aa75ed71a1\/language-en."},{"issue":"12","key":"5760_CR14","doi-asserted-by":"publisher","first-page":"2821","DOI":"10.1099\/vir.0.031641-0","volume":"92","author":"KL Mansfield","year":"2011","unstructured":"Mansfield KL, Horton DL, Johnson N, Li L, Barrett ADT, Smith DJ, et al. Flavivirus-induced antibody cross-reactivity. J Gen Virol. 2011;92(12):2821\u20139 [cited 2020 Aug 29] Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/21900425\/.","journal-title":"J Gen Virol"},{"issue":"1\u20132","key":"5760_CR15","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.jviromet.2007.05.021","volume":"146","author":"S Linke","year":"2007","unstructured":"Linke S, Ellerbrok H, Niedrig M, Nitsche A, Pauli G. Detection of West Nile virus lineages 1 and 2 by real-time PCR. J Virol Methods. 2007;146(1\u20132):355\u20138 [cited 2020 Aug 29]Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/17604132\/.","journal-title":"J Virol Methods"},{"issue":"1\u20132","key":"5760_CR16","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.vetmic.2013.03.005","volume":"165","author":"T Bakonyi","year":"2013","unstructured":"Bakonyi T, Ferenczi E, Erd\u00e9lyi K, Kutasi O, Cs\u00f6rgo T, Seidel B, et al. Explosive spread of a neuroinvasive lineage 2 West Nile virus in Central Europe, 2008\/2009. Vet Microbiol. 2013;165(1\u20132):61\u201370 Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/23570864\/.","journal-title":"Vet Microbiol"},{"issue":"7","key":"5760_CR17","doi-asserted-by":"publisher","first-page":"589","DOI":"10.3390\/pathogens9070589","volume":"9","author":"G Habarugira","year":"2020","unstructured":"Habarugira G, Suen WW, Hobson-Peters J, Hall RA, Bielefeldt-Ohmann H. West Nile virus: an update on pathobiology, epidemiology, diagnostics, control and \u201cone health\u201d implications. Pathogens. 2020;9(7):589 Available from: \/pmc\/articles\/PMC7400489\/?report=abstract.","journal-title":"Pathogens"},{"issue":"11","key":"5760_CR18","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1089\/vbz.2018.2401","volume":"19","author":"A Nagy","year":"2019","unstructured":"Nagy A, Sz\u00f6llosi T, Tak\u00e1cs M, Magyar N, Barab\u00e1s \u00c9. West Nile virus seroprevalence among blood donors in Hungary. Vector-Borne Zoonotic Dis. 2019;19(11):844\u201350 Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/31184991\/.","journal-title":"Vector-Borne Zoonotic Dis"},{"key":"5760_CR19","unstructured":"GenBank Overview [Internet]. Ncbi.nlm.nih.gov. 2021 [cited 5 January 2021]. Available from: https:\/\/www.ncbi.nlm.nih.gov\/genbank\/."},{"issue":"6","key":"5760_CR20","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1212\/WNL.45.6.1115","volume":"45","author":"PJ Dyck","year":"1995","unstructured":"Dyck PJ, Litchy WJ, Hokanson JL, Low JL, O\u2019Brien PC. Variables influencing neuropathic endpoints: The rochester diabetic neuropathy study of healthy subjects. Neurology. 1995;45(6):1115\u201321 [cited 2020 Aug 29] Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/7783874\/.","journal-title":"Neurology"},{"issue":"6","key":"5760_CR21","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1002\/ana.410080608","volume":"8","author":"PJ Dyck","year":"1980","unstructured":"Dyck PJ, Sherman WR, Hallcher LM, John Service F, O\u2019Brien PC, Grina LA, et al. Human diabetic endoneurial sorbitol, fructose, and myo-inositol related to sural nerve morphometry. Ann Neurol. 1980;8(6):590\u20136 [cited 2020 Aug 29] Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/7212646\/.","journal-title":"Ann Neurol"},{"issue":"4","key":"5760_CR22","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1001\/jama.290.4.511","volume":"290","author":"JJ Sejvar","year":"2003","unstructured":"Sejvar JJ, Haddad MB, Tierney BC, Campbell GL, Marfin AA, Van Gerpen JA, et al. Neurologic manifestations and outcome of West Nile Virus infection. J Am Med Assoc. 2003;290(4):511\u20135 [cited 2020 Nov 28] Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/12876094\/.","journal-title":"J Am Med Assoc"},{"issue":"5","key":"5760_CR23","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1161\/01.STR.19.5.604","volume":"19","author":"JC Van Swieten","year":"1988","unstructured":"Van Swieten JC, Koudstaal PJ, Visser MC, Schouten H, Van Gijn J. Interobserver agreement for the assessment of handicap in stroke patients. Stroke. 1988;19(5):604\u20137 [cited 2020 Aug 29] Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/3363593\/.","journal-title":"Stroke"},{"issue":"10","key":"5760_CR24","doi-asserted-by":"publisher","first-page":"3393","DOI":"10.1161\/STROKEAHA.109.557256","volume":"40","author":"TJ Quinn","year":"2009","unstructured":"Quinn TJ, Dawson J, Walters MR, Lees KR. Reliability of the modified rankin scale: A systematic review. Stroke. 2009;40(10):3393\u20135 [cited 2020 Aug 29] Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/19679846\/.","journal-title":"Stroke"},{"key":"5760_CR25","doi-asserted-by":"publisher","unstructured":"Wilson JTL, Hareendran A, Grant M, Baird T, Schulz UGR, Muir KW, et al. Improving the assessment of outcomes in stroke: Use of a structured interview to assign grades on the modified Rankin Scale. Stroke. 2002 ;33(9):2243\u20132246. [cited 2020 Nov 28] Available from: https:\/\/www.ahajournals.org\/doi\/https:\/\/doi.org\/10.1161\/01.STR.0000027437.22450.BD.","DOI":"10.1161\/01.STR.0000027437.22450.BD"},{"key":"5760_CR26","doi-asserted-by":"publisher","unstructured":"Mada PK, Sneed P, Castano G, et al. Retrospective Descriptive Analysis of West Nile Neuroinvasive Disease (WNND) in Northwest Louisiana. Int J Microbiol. 2020;2020:3513859. https:\/\/doi.org\/10.1155\/2020\/3513859.","DOI":"10.1155\/2020\/3513859"},{"key":"5760_CR27","doi-asserted-by":"publisher","unstructured":"Zana B, Erd\u00e9lyi K, Nagy A, et al. Multi-Approach Investigation Regarding the West Nile Virus Situation in Hungary, 2018. Viruses. 2020;12(1):123. https:\/\/doi.org\/10.3390\/v12010123.","DOI":"10.3390\/v12010123"},{"key":"5760_CR28","doi-asserted-by":"publisher","unstructured":"Fall G, Di Paola N, Faye M, et al. Biological and phylogenetic characteristics of West African lineages of West Nile virus. PLoS Negl Trop Dis. 2017;11(11):e0006078. https:\/\/doi.org\/10.1371\/journal.pntd.0006078.","DOI":"10.1371\/journal.pntd.0006078"},{"issue":"1\u20132","key":"5760_CR29","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.vetmic.2013.03.005","volume":"165","author":"T Bakonyi","year":"2013","unstructured":"Bakonyi T, Ferenczi E, Erd\u00e9lyi K, Kutasi O, Cs\u00f6rgo T, Seidel B, et al. Explosive spread of a neuroinvasive lineage 2 West Nile virus in Central Europe, 2008\/2009. Vet Microbiol. 2013;165(1\u20132):61\u201370 [cited 2020 Aug 27] Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/23570864\/.","journal-title":"Vet Microbiol"},{"issue":"5 Suppl","key":"5760_CR30","doi-asserted-by":"publisher","first-page":"33S","DOI":"10.1177\/1545968311410942","volume":"25","author":"V Pomeroy","year":"2011","unstructured":"Pomeroy V, Aglioti SM, Mark VW, Mcfarland D, Stinear C, Wolf SL, et al. Neurological Principles and Rehabilitation of Action Disorders: Rehabilitation Interventions. Neurorehabil Neural Repair. 2011;25(5 Suppl):33S\u201343S [cited 2020 Aug 30] Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/21613536\/.","journal-title":"Neurorehabil Neural Repair"},{"issue":"7","key":"5760_CR31","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.3201\/eid1107.040991","volume":"11","author":"JJ Sejvar","year":"2005","unstructured":"Sejvar JJ, Bode AV, Marfin AA, Campbell GL, Ewing D, Mazowiecki M, et al. West Nile virus-associated flaccid paralysis. Emerg Infect Dis. 2005;11(7):1021\u20137 [cited 2020 Aug 30] Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/16022775\/.","journal-title":"Emerg Infect Dis"},{"key":"5760_CR32","doi-asserted-by":"crossref","unstructured":"DeBiasi RL, Tyler KL. West Nile virus meningoencephalitis [Internet]. Nat Clin Pract Neurol. 2006;2:264\u201375 [cited 2020 Aug 30] Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/16932563\/.","DOI":"10.1038\/ncpneuro0176"},{"key":"5760_CR33","doi-asserted-by":"crossref","unstructured":"Jennett B, Snoek J, Bond MR, Brooks N. Disability after severe head injury: Observations on the use of the Glasgow Outcome Scale. J Neurol Neurosurg Psychiatry. 1981, 44(4):285\u201393 [cited 2020 Aug 30] Available from: \/pmc\/articles\/PMC490949\/?report=abstract.","DOI":"10.1136\/jnnp.44.4.285"},{"issue":"8","key":"5760_CR34","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1089\/vbz.2019.2608","volume":"20","author":"A Mrzljak","year":"2020","unstructured":"Mrzljak A, Dinjar-Kujundzic P, Santini M, Barbic L, Kosuta I, Savic V, et al. West Nile Virus: an emerging threat in transplant population. Vector Borne Zoonotic Dis. 2020;20(8):613\u20138 Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/32228360\/.","journal-title":"Vector Borne Zoonotic Dis"},{"issue":"1","key":"5760_CR35","doi-asserted-by":"publisher","first-page":"179","DOI":"10.4269\/ajtmh.2012.12-0113","volume":"87","author":"NP Lindsey","year":"2012","unstructured":"Lindsey NP, Staples JE, Lehman JA, Fischer M. Medical risk factors for severe West Nile virus disease, United States, 2008-2010. Am J Trop Med Hyg. 2012;87(1):179\u201384 Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/22764311\/.","journal-title":"Am J Trop Med Hyg"},{"issue":"11","key":"5760_CR36","first-page":"1399","volume":"168","author":"C Pepperell","year":"2003","unstructured":"Pepperell C, Rau N, Krajden S, Kern R, Humar A, Mederski B, et al. West Nile virus infection in 2002: Morbidity and mortality among patients admitted to hospital in southcentral Ontario. CMAJ. 2003;168(11):1399\u2013405 Available from: www.cmaj.ca.","journal-title":"CMAJ"},{"key":"5760_CR37","unstructured":"Chirico F, Magnavita N. Commentary West Nile virus infection in Europe: Need for an integration of occupational health practice and public health activities . Vol. 55, Annali dell\u2019Istituto Superiore di Sanita. Istituto Superiore di Sanita; 2019 [cited 2020 Aug 26]. p. 3\u20135. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/30968829\/."},{"key":"5760_CR38","doi-asserted-by":"publisher","unstructured":"Campbell G, Lanciotti R. Laboratory-Acquired West Nile Virus Infections\u2014United States, 2002. Appl Biosaf. 2003 ;8(1):17\u201319. [cited 2020 Aug 26] Available from: http:\/\/journals.sagepub.com\/doi\/https:\/\/doi.org\/10.1177\/153567600300800104.","DOI":"10.1177\/153567600300800104"},{"issue":"5","key":"5760_CR39","doi-asserted-by":"publisher","first-page":"747","DOI":"10.3201\/eid1405.071347","volume":"14","author":"RM Carney","year":"2008","unstructured":"Carney RM, Husted S, Jean C, Glaser C, Kramer V. Efficacy of aerial spraying of mosquito adulticide in reducing incidence of West Nile Virus, California, 2005. Emerg Infect Dis. 2008;14(5):747\u201354 [cited 2020 Aug 30]Available from: \/pmc\/articles\/PMC2600250\/?report=abstract.","journal-title":"Emerg Infect Dis"},{"key":"5760_CR40","doi-asserted-by":"crossref","unstructured":"Cantier M, Morisot A, Gu\u00e9rot E, Megarbane B, Razazi K, Contou D, et al. Functional outcomes in adults with tuberculous meningitis admitted to the ICU: A multicenter cohort study. Crit Care. 2018 ;22(1). [cited 2020 Aug 30] Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/30119686\/.","DOI":"10.1186\/s13054-018-2140-8"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-020-05760-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12879-020-05760-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-020-05760-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,13]],"date-time":"2021-01-13T20:06:05Z","timestamp":1610568365000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-020-05760-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,13]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["5760"],"URL":"https:\/\/doi.org\/10.1186\/s12879-020-05760-7","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,13]]},"assertion":[{"value":"24 September 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 December 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was carried out according to the Good Clinical Practice guidelines of the Helsinki declaration. The study was approved by the Regional Ethical Committee of Somogy County Kaposi M\u00f3r Teaching Hospital (Somogy County Kaposi M\u00f3r Teaching Hospital, Kaposv\u00e1r; Ethical Approval Number: IG\/00759\u2013000\/2019).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"65"}}